Clene Inc. — Director's Dealing 2021

Jul 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clene Inc. (CLNN)
CIK: 0001822791
Period of Report: 2021-06-30

Reporting Person: Etherington Robert Dee (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-30	Common Stock	A	80076.00	$0.00	Acquired	80076.00	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12717.00	Indirect

Footnotes

F1: This restricted stock award was granted on June 30, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on January 15, 2022.

F2: The securities are owned by RDE RX Ventures LLC. Mr. Etherington is the manager of RDE RX Ventures LLC. The shares owned by RDE RX Ventures LLC may also be deemed to be beneficially owned by Mr. Etherington.